Efficacy Of Two Anti-VEGF Drugs In The Treatment Of Age-related Macular Degeneration

ObjectiveTo evaluate efficacy of Ranibizumab and Conbercept for the treatment of wet age— related macular degeneration(w AMD).MethodsThis is a retrospective case series study.Thirty patiens(30 eyes)with w AMDwere enrolled to receive intravitreal injections of ranibizumab(0.5mg)on 3 consecutive monthly schedule and twenty-eight patiens(30 eyes)with w AMD were enrolled to receive intravitreal injections of conbercept(0.5 mg)on 3 consecutive monthly schedule.Compare them in glass body cavity medicine injection in one month after the the best corrected visual acuity(BCVA),optic coherence tomography(OCT).ResultsOne month after the treatment:the BCVA increased while the CMT decreased compared with that of pretreatment in groups A and B(P <0.05)on 3 consecutive monthly schedule.BCVA and CMT changes between two groups were no statistically significant difference(P > 0.05).Conclusion:Ranibizumab and Conbercept therapy can control wet AMD patients todevelop and improve your vision effectively,the curative effect of two drugs compared three months no statistical significance.Conclusions:The treatment of Ranibizumab and Conbercept can effectively control the development and improvement of visual acuity in patients with w AMD.There was no significant difference between the two drugs in the treatment of 3Mo.